Stay updated on Pembrolizumab and Olaparib in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab and Olaparib in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab and Olaparib in NSCLC Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The record history now lists revision v3.6.3 as the current version, updating the page's metadata.
    Difference
    0.0%
    Check dated 2026-07-05T13:16:37.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The page's revision label changed from v3.6.0 to v3.6.2. This reflects a new revision published in the history rather than a substantive change to content.
    Difference
    0.0%
    Check dated 2026-06-28T04:50:38.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    The history now shows that enrollment is closed ('No longer looking for participants'), adds a new revision entry 'Revision: v3.6.0', and removes the previous revision entry 'Revision: v3.5.5' from the record.
    Difference
    0.1%
    Check dated 2026-06-13T17:33:33.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    The page history now shows a new Revision: v3.5.5 tag, replacing the previous v3.5.4 tag, indicating a UI/version update in the history view.
    Difference
    0.0%
    Check dated 2026-06-06T13:20:16.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    The page history now includes a new revision tag, Revision: v3.5.4, replacing the previous Revision: v3.5.3. This reflects a minor update to the page's release version.
    Difference
    0.0%
    Check dated 2026-05-15T23:51:59.000Z thumbnail image
  7. Check
    78 days ago
    Change Detected
    Summary
    The page’s displayed UI/release revision changes from v3.5.2 to v3.5.3.
    Difference
    0.0%
    Check dated 2026-04-24T06:11:49.000Z thumbnail image

Stay in the know with updates to Pembrolizumab and Olaparib in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Olaparib in NSCLC Clinical Trial page.